The Week’s Investing News Roundup: Johnson & Johnson, JPMorgan, Dividend and Buffett Stocks

• Holiday sales were strong as prepandemic spending returned.
• The S&P 500 flirted with an all-time high.
• AstraZeneca and Bristol Myers Squibb made big acquisitions.
• The New York Times sued Microsoft and OpenAI over use of copyrighted material.
• Angola left OPEC.

6 Ultra-Yield Dividend Stocks Are Growing at Blazing Speeds

Six top companies that pay among the highest dividends on Wall Street, including Energy Transfer and Verizon, are also growing their businesses fast through multiple corporate silos.

6 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole

Investors should avoid these six dividend stocks that have announced they will cut their payouts to investors in a big way, as their shares could be in trouble.

6 Reasons to Avoid Johnson & Johnson at All Costs

Despite it paying a solid dividend and being perceived as a safe stock for conservative investors, we found six reasons investors should avoid Johnson & Johnson at all costs.

7 Stocks That Are Ready for Dividend Hikes in 2024

Growth and income investors will want to consider these seven top Strong Buy-rated stocks, including AT&T, IBM and Kinder Morgan, that are all candidates to raise their dividends in the coming year.

6 Reasons to Avoid JPMorgan Stock Immediately

It may be the largest bank in the world, but here is why investors looking to buy shares of JPMorgan with the stock at all-time highs may want to reconsider.

Buffett, Dollar Tree Purchases Highlight Pre-Christmas Insider Buying

Warren Buffett’s Berkshire Hathaway has again bolstered its stake in Occidental Petroleum, and action at Dollar Tree also highlights recent insider buying.

By Trey Thoelcke